You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Automatic Detection and Patching of Vulnerabilities in Embedded Systems
SBC: GRAMMATECH INC Topic: SB131003Recent studies have shown that embedded systems are extremely vulnerable to security attacks. Some published exploits include remote hijacking of the electronic systems in a modern car and using IP phones and smart televisions to perform covert surveillance of their owners. In this project, we propose a protection system that automatically detects and removes vulnerabilities from embedded software ...
SBIR Phase I 2013 Department of DefenseDefense Advanced Research Projects Agency -
Biodegradable, Biocompatible Conductor for Resorbable Medical Implants
SBC: TDA RESEARCH, INC. Topic: SB131005Advances in biodegradable materials have allowed the development of a variety of resorbable medical devices that do no need to be removed at the end of their service because they degrade within the body into not toxic by-products. However, devices that contain electronic components are still nearly all non-degradable because of the lack of biodegradable conducting and semiconducting materials. T ...
SBIR Phase I 2013 Department of DefenseDefense Advanced Research Projects Agency -
Surface Enhanced Raman Scattering-Based Oxytocin Quantitation
SBC: Ionica Sciences, Inc Topic: SB132001The ability to readily and rapidly detect the concentration of the 9- and 12-amino acid oxytocin analogs will significantly enhance the efficacy of understanding the conditions under which oxytocin is employed by the body. Ionica Sciences will take advantage of recent miniaturization of highly sensitive instrumentation that allows field application of surface enhanced Raman scattering (SERS), a sp ...
SBIR Phase I 2013 Department of DefenseDefense Advanced Research Projects Agency -
Online Graphic Novel/Sequential Art Authoring Tools for Therapeutic Storytelling
SBC: E-Line Ventures, LLC Topic: SB112003Addressing PTSD and related stress reactions by Service Members and Veterans is one of our country's most important public health challenges. Art therapy has been recognized as a powerful tool enabling"trauma survivors to symbolically express, process and contain feelings they find difficult or impossible to put in to words"(Buk, 2009). Enabling Service Members and Veterans to tell their st ...
SBIR Phase II 2013 Department of DefenseDefense Advanced Research Projects Agency -
PNA-Based Rapidly Adaptable Anti-Microbial Nanoparticles
SBC: AGAVE BIOSYSTEMS INC. Topic: SB121003Wound management becomes increasingly challenging due to bacterial infections, especially from epidemic drug-resistant strains. To address this problem, Agave BioSystems proposes to develop a RANT (Rapidly Adaptable Nanotherapeutics) breadboard system built upon the modules successfully established in Phase I of this work. The proposed breadboard system will use genomic sequencing data generated ...
SBIR Phase II 2013 Department of DefenseDefense Advanced Research Projects Agency -
Frequency Stabilized Laser for use in Microwave Generation
SBC: Boulder Precision Electro-optics Topic: SB121001This project aims to further develop the technology of frequency stabilized lasers for microwave generation, laser radar and other precision measurement applications. The goal is to decrease the noise floor of the stabilized laser to ~ 6 x 10^-16 at 1 s, and improve operational robustness to allow the device to be transported and operated at the Hz level in stand-alone operation, and mitigate the ...
SBIR Phase II 2013 Department of DefenseDefense Advanced Research Projects Agency -
A collagen wound dressing augmented with a proteoglycan mimic to enhance chronic
SBC: Angion Biomedica Corp. Topic: NIAAADESCRIPTION (provided by applicant): Liver fibrosis is a form of scar formation that is found in almost all patients with chronic injury to the liver. Over time it frequently progresses to cirrhosis, an end-stage lethal disease which is the seventh leadingcause of death in the United States and afflicts hundreds of millions of people worldwide. Alcohol intake remains the most important cause of li ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Reversal of Myocardial Infarction by Localized Stimulation
SBC: GISMO THERAPEUTICS INC. Topic: NIADESCRIPTION (provided by applicant): The aim of this proposal is to develop a novel class of Alzheimer's Disease (AD) therapeutics acting via a hitherto unexplored mechanism of action. AD is the sixth-leading cause of death in the United States with no known cure. The burden on families and caregivers of patients is immense, with the annual cost of care approaching 1 trillion. The exorbitant ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Medicinal Chemistry Based Optimization of Lead Compounds Against Multiple Scleros
SBC: Adhaere Pharmaceuticals, Inc. Topic: NIAIDDESCRIPTION (provided by applicant): Multiple Sclerosis (MS) is an autoimmune disease that affects the central nervous system (CNS) and results in neurological and clinical disability i number of adults in the US. Leukocyte infiltration and plaques of demyelination in the brain and spinal cord of patients are a hallmark of MS. Currently, there is no cure and few therapies for this debilitating ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
A novel, multiparametric cardiac safety assay using human myocytes
SBC: THERAPYX, INC. Topic: NIAIDDESCRIPTION (provided by applicant): Genital tract infection with Neisseria gonorrhoeae (gonorrhea) does not induce a state of specific protective immunity and can be acquired repeatedly. Despite public health measures, the disease persists at an unacceptably high frequency; there is no vaccine against it, and resistance even to the latest generations of antibiotics continues to emerge. New findin ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health